{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:41:18Z","timestamp":1790725278626,"version":"4.1.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1681\/asn.2014111097","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T23:37:02Z","timestamp":1428536222000},"page":"3009-3019","source":"Crossref","is-referenced-by-count":30,"title":["Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome"],"prefix":"10.1681","volume":"26","author":[{"given":"Bryce A.","family":"Kerlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda P.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda A.","family":"Chanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin T.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Smoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20230208","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood.","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"R2-17-20230208","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199804233381707","article-title":"The nephrotic syndrome.","volume":"338","author":"Orth","year":"1998","journal-title":"N Engl J Med"},{"key":"R3-17-20230208","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease.","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-17-20230208","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMcibr1209459","article-title":"Venous thrombosis in the nephrotic syndrome.","volume":"368","author":"Loscalzo","year":"2013","journal-title":"N Engl J Med"},{"key":"R5-17-20230208","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-996100","article-title":"Thromboembolic risks and complications in nephrotic children.","volume":"23","author":"Schlegel","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"R6-17-20230208","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","article-title":"Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management.","volume":"118","author":"Singhal","year":"2006","journal-title":"Thromb Res"},{"key":"R7-17-20230208","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00467-013-2525-5","article-title":"Venous thromboembolism in pediatric nephrotic syndrome.","volume":"29","author":"Kerlin","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R8-17-20230208","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jth.12652","article-title":"Kidney disease and risk of venous thromboembolism: A nationwide population-based case-control study.","volume":"12","author":"Christiansen","year":"2014","journal-title":"J Thromb Haemost"},{"key":"R10-17-20230208","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2006111300","article-title":"Prophylactic anticoagulation in nephrotic syndrome: A clinical conundrum.","volume":"18","author":"Glassock","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R11-17-20230208","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ki.2013.476","article-title":"Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.","volume":"85","author":"Lee","year":"2014","journal-title":"Kidney Int"},{"key":"R12-17-20230208","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ki.1994.75","article-title":"Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy.","volume":"45","author":"Sarasin","year":"1994","journal-title":"Kidney Int"},{"key":"R13-17-20230208","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2369-13-107","article-title":"Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: An observational study.","volume":"13","author":"Kumar","year":"2012","journal-title":"BMC Nephrol"},{"key":"R14-17-20230208","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2215\/CJN.04250511","article-title":"Venous thromboembolism in patients with membranous nephropathy.","volume":"7","author":"Lionaki","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R15-17-20230208","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000187205","article-title":"Membranous nephropathy and thromboembolism: Is prophylactic anticoagulation warranted?","volume":"63","author":"Bellomo","year":"1993","journal-title":"Nephron"},{"key":"R16-17-20230208","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ki.2011.312","article-title":"Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis.","volume":"81","author":"Barbour","year":"2012","journal-title":"Kidney Int"},{"key":"R17-17-20230208","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpeds.2009.01.070","article-title":"Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: A Midwest Pediatric Nephrology Consortium (MWPNC) study.","volume":"155","author":"Kerlin","year":"2009","journal-title":"J Pediatr"},{"key":"R18-17-20230208","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: Results from a large retrospective cohort study.","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"R19-17-20230208","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000188312","article-title":"Abnormalities of coagulation in experimental nephrotic syndrome.","volume":"68","author":"Cruz","year":"1994","journal-title":"Nephron"},{"key":"R20-17-20230208","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0049-3848(79)90208-1","article-title":"Delayed hypercoagulability after a single dose of adriamycin to normal rats.","volume":"16","author":"Poggi","year":"1979","journal-title":"Thromb Res"},{"key":"R21-17-20230208","doi-asserted-by":"crossref","first-page":"F213","DOI":"10.1152\/ajprenal.90421.2008","article-title":"Inducible rodent models of acquired podocyte diseases.","volume":"296","author":"Pippin","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R22-17-20230208","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1046\/j.1523-1755.2001.00047.x","article-title":"Podocyte injuries exacerbate mesangial proliferative glomerulonephritis.","volume":"60","author":"Morioka","year":"2001","journal-title":"Kidney Int"},{"key":"R23-17-20230208","doi-asserted-by":"crossref","first-page":"F503","DOI":"10.1152\/ajprenal.2001.281.3.F503","article-title":"Puromycin aminonucleoside damages the glomerular size barrier with minimal effects on charge density.","volume":"281","author":"Hjalmarsson","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"R24-17-20230208","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2362.2011.02602.x","article-title":"Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease.","volume":"42","author":"Ay","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"R25-17-20230208","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1538-7836.2008.03117.x","article-title":"High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study.","volume":"6","author":"Besser","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R26-17-20230208","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jama.296.4.397","article-title":"Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation.","volume":"296","author":"Hron","year":"2006","journal-title":"JAMA"},{"key":"R27-17-20230208","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood-2011-06-362814","article-title":"Procoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice.","volume":"118","author":"Machlus","year":"2011","journal-title":"Blood"},{"key":"R28-17-20230208","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1111\/j.1538-7836.2011.04525.x","article-title":"The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuria.","volume":"9","author":"Mahmoodi","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R29-17-20230208","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/ATVBAHA.112.250332","article-title":"Diet modulates endogenous thrombin generation, a biological estimate of thrombosis risk, independently of the metabolic status.","volume":"32","author":"Sanchez","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R30-17-20230208","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.thromres.2011.12.006","article-title":"Global haemostasis assays, from bench to bedside.","volume":"129","author":"van Geffen","year":"2012","journal-title":"Thromb Res"},{"key":"R31-17-20230208","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1476-4431.2011.00656.x","article-title":"Examination of hemostatic parameters to detect hypercoagulability in dogs with severe protein-losing nephropathy.","volume":"21","author":"Donahue","year":"2011","journal-title":"J Vet Emerg Crit Care (San Antonio"},{"key":"R32-17-20230208","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/jvim.12067","article-title":"Hypercoagulability in dogs with protein-losing nephropathy as assessed by thromboelastography.","volume":"27","author":"Lennon","year":"2013","journal-title":"J Vet Intern Med"},{"key":"R33-17-20230208","first-page":"111","article-title":"Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer.","volume":"29","author":"Papa","year":"2007","journal-title":"Exp Oncol"},{"key":"R34-17-20230208","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.thromres.2013.06.009","article-title":"Whole blood rotation thromboelastometry (ROTEM\u00ae) profiles in subjects with non-neoplastic portal vein thrombosis.","volume":"132","author":"Rossetto","year":"2013","journal-title":"Thromb Res"},{"key":"R35-17-20230208","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00464-013-3203-1","article-title":"Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery.","volume":"28","author":"Taura","year":"2014","journal-title":"Surg Endosc"},{"key":"R36-17-20230208","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.thromres.2013.01.031","article-title":"A novel approach for detecting hypercoagulability utilizing thromboelastography.","volume":"131","author":"Ko","year":"2013","journal-title":"Thromb Res"},{"key":"R37-17-20230208","doi-asserted-by":"crossref","first-page":"C634","DOI":"10.1152\/ajpcell.1988.254.5.C634","article-title":"Effects of experimentally induced nephrosis on protein synthesis in rat liver.","volume":"254","author":"Lewandowski","year":"1988","journal-title":"Am J Physiol"},{"key":"R38-17-20230208","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj2260243","article-title":"Effects of experimental nephrosis on basement-membrane components and enzymes of collagen biosynthesis in rat kidney.","volume":"226","author":"Jukkola","year":"1985","journal-title":"Biochem J"},{"key":"R39-17-20230208","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1074\/jbc.273.8.4769","article-title":"Protein synthesis inhibitors exhibit a nonspecific effect on phenobarbital-inducible cytochome P450 gene expression in primary rat hepatocytes.","volume":"273","author":"Sidhu","year":"1998","journal-title":"J Biol Chem"},{"key":"R40-17-20230208","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mrd.1080270309","article-title":"Protein synthesis inhibitors prevent both spontaneous and hormone-dependent maturation of isolated mouse oocytes.","volume":"27","author":"Downs","year":"1990","journal-title":"Mol Reprod Dev"},{"key":"R41-17-20230208","first-page":"40","article-title":"Puromycin aminonucleoside and adriamycin disturb cytoskeletal and extracellular matrix protein organization, but not protein synthesis of cultured glomerular epithelial cells.","volume":"2","author":"Coers","year":"1994","journal-title":"Exp Nephrol"},{"key":"R42-17-20230208","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-80-2-249","article-title":"Adriamycin. A new anticancer drug with significant clinical activity.","volume":"80","author":"Blum","year":"1974","journal-title":"Ann Intern Med"},{"key":"R43-17-20230208","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/0310057X1204000313","article-title":"In vitro thrombotic tendency of reactive thrombocytosis in critically ill patients: A prospective case-control study.","volume":"40","author":"Duff","year":"2012","journal-title":"Anaesth Intensive Care"},{"key":"R44-17-20230208","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejphar.2005.03.009","article-title":"Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models.","volume":"514","author":"Furugohri","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R45-17-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5001\/omj.2012.127","article-title":"Anti-platelet and anti-thrombotic effects of a poly-ingredient formulation: In vitro and in vivo experimental evidences","volume":"27","author":"Viswanatha","year":"2012","journal-title":"Oman Med J"},{"key":"R46-17-20230208","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/ATVBAHA.109.185678","article-title":"Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats.","volume":"29","author":"Zhou","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R47-17-20230208","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.thromres.2012.02.036","article-title":"Murine models of thrombosis.","volume":"129","author":"Cooley","year":"2012","journal-title":"Thromb Res"},{"key":"R48-17-20230208","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/ATVBAHA.111.244608","article-title":"Critical review of mouse models of venous thrombosis.","volume":"32","author":"Diaz","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R49-17-20230208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1160\/TH07-04-0277","article-title":"Antithrombin\u2014early prophecies and present challenges.","volume":"98","author":"Abildgaard","year":"2007","journal-title":"Thromb Haemost"},{"key":"R50-17-20230208","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0049-3848(79)90105-1","article-title":"Heparin like activity of albumin.","volume":"16","author":"J\u00f8orgensen","year":"1979","journal-title":"Thromb Res"},{"key":"R51-17-20230208","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1093\/ndt\/gfp117","article-title":"Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.","volume":"24","author":"Matsui","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R52-17-20230208","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/jclinpath-2011-200613","article-title":"High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: Cross-sectional study.","volume":"65","author":"Broder","year":"2012","journal-title":"J Clin Pathol"},{"key":"R53-17-20230208","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00109-005-0013-5","article-title":"Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression.","volume":"84","author":"Inoue","year":"2006","journal-title":"J Mol Med (Berl"},{"key":"R54-17-20230208","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/pr.54.1.129","article-title":"Liver-enriched transcription factors in liver function and development. Part I: The hepatocyte nuclear factor network and liver-specific gene expression.","volume":"54","author":"Schrem","year":"2002","journal-title":"Pharmacol Rev"},{"key":"R55-17-20230208","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/prca.201100081","article-title":"Plasma and urine proteomic profiles in childhood idiopathic nephrotic syndrome.","volume":"6","author":"Andersen","year":"2012","journal-title":"Proteomics Clin Appl"},{"key":"R56-17-20230208","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1182\/blood-2010-10-314773","article-title":"Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: Protective effect of factor V Leiden in diabetic nephropathy.","volume":"117","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"R57-17-20230208","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejphar.2008.04.065","article-title":"Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.","volume":"589","author":"Yamashita","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R58-17-20230208","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1182\/blood-2012-08-378935","article-title":"Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: Current state of art and future perspectives.","volume":"121","author":"Young","year":"2013","journal-title":"Blood"},{"key":"R59-17-20230208","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.thromres.2009.11.012","article-title":"Standardisation of thrombin generation test\u2014which reference plasma for TGT? An international multicentre study.","volume":"125","author":"Dargaud","year":"2010","journal-title":"Thromb Res"},{"key":"R60-17-20230208","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.thromres.2012.07.017","article-title":"Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study.","volume":"130","author":"Dargaud","year":"2012","journal-title":"Thromb Res"},{"key":"R61-17-20230208","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0049-3848(75)90078-X","article-title":"Heparin cofactor activity measured with an amidolytic method.","volume":"6","author":"Odegard","year":"1975","journal-title":"Thromb Res"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201512000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:15Z","timestamp":1786130775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201512000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014111097","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}